MYND Diagnostics to assess MAP biomarker test usage for Multiple Sclerosis
The clinical research will assess the MAP biomarker test for the diagnosis of Multiple Sclerosis.
Clinical Trials
Cardialen gets FDA approval for study of MultiPulse Therapy
The clinical trial will assess the performance and safety of MultiPulse Therapy in paroxysmal and...
Bluestar Genomics reports data on non-invasive pancreatic cancer test
The epigenomics technology platform leverages machine learning and a DNA-based 5hmC biomarker for early-stage cancer...
Rapid progress and critical setbacks highlight robotic surgical systems market
The RAS systems market is expected to grow at a CAGR of 7.6% to $3.2bn...
Could Africa become a clinical trial powerhouse?
Despite the clinical advantages, Africa contributes to a tiny proportion of the total number of...
Smart Medical’s G-Eye balloon technology increases colon adenoma detection
The G-EYE balloon technology showed an 18% increase in overall ADR and 69% increase in ADR of advanced adenomas.
Ocular’s OTX-CSI fails to meet primary endpoint in dry eye disease trial
The durability, tolerability, safety and efficacy of two different formulations of OTX-CSI were evaluated in the Phase II trial.
Curebase and Checkable Medical to evaluate strep throat test kits
The initial stage of the clinical trial will take place in four regions and include 100 subjects with sore throats.
Aerin Medical RHINTRAC clinical trial reports positive results
The trial data demonstrated that the RhinAer technology is safe and helps in reducing chronic rhinitis symptoms.
NIH awards $10m grant for Synchron’s brain computer interface study
The study, referred to as the COMMAND trial, will include six severely paralysed patients.
Diadem blood test accurately predicts early Alzheimer’s, study finds
AlzoSure Predict identifies individuals who will progress to Alzheimer's Disease up to six years before diagnosis.
